n(g),n(g')-dimethyl-l-arginine has been researched along with Cerebrovascular Disorders in 11 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide (NO) synthesis causing endothelial dysfunction, an early sign of atherogenesis." | 5.37 | Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial disease. ( Atzler, D; Benndorf, RA; Böger, RH; Darius, H; Diehm, C; Endres, HG; Lüneburg, N; Maas, R; Schwedhelm, E; Thiem, U; von Stritzky, B, 2011) |
| "Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide (NO) synthesis causing endothelial dysfunction, an early sign of atherogenesis." | 1.37 | Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial disease. ( Atzler, D; Benndorf, RA; Böger, RH; Darius, H; Diehm, C; Endres, HG; Lüneburg, N; Maas, R; Schwedhelm, E; Thiem, U; von Stritzky, B, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, S | 1 |
| Singh, I | 1 |
| Singh, AK | 1 |
| Khan, M | 1 |
| Won, J | 1 |
| Bouras, G | 1 |
| Deftereos, S | 1 |
| Tousoulis, D | 1 |
| Giannopoulos, G | 1 |
| Chatzis, G | 1 |
| Tsounis, D | 1 |
| Cleman, MW | 1 |
| Stefanadis, C | 1 |
| Yousefi, B | 1 |
| Faghfoori, Z | 1 |
| Samadi, N | 1 |
| Karami, H | 1 |
| Ahmadi, Y | 1 |
| Badalzadeh, R | 1 |
| Shafiei-Irannejad, V | 1 |
| Majidinia, M | 1 |
| Ghavimi, H | 1 |
| Jabbarpour, M | 1 |
| Notsu, Y | 1 |
| Nabika, T | 1 |
| Bokura, H | 1 |
| Suyama, Y | 1 |
| Kobayashi, S | 1 |
| Yamaguchi, S | 1 |
| Masuda, J | 1 |
| Sobczak, A | 1 |
| Goniewicz, ML | 1 |
| Szoltysek-Boldys, I | 1 |
| Kielstein, JT | 2 |
| Kielstein, A | 1 |
| Böger, RH | 1 |
| Endres, HG | 1 |
| Schwedhelm, E | 1 |
| Darius, H | 1 |
| Atzler, D | 1 |
| Lüneburg, N | 1 |
| von Stritzky, B | 1 |
| Maas, R | 1 |
| Thiem, U | 1 |
| Benndorf, RA | 1 |
| Diehm, C | 1 |
| Bugnicourt, JM | 1 |
| Da Silveira, C | 1 |
| Bengrine, A | 1 |
| Godefroy, O | 1 |
| Baumbach, G | 1 |
| Sevestre, H | 1 |
| Bode-Boeger, SM | 1 |
| Massy, ZA | 1 |
| Chillon, JM | 1 |
| Tsuda, K | 2 |
| Khan, U | 1 |
| Hassan, A | 1 |
| Vallance, P | 1 |
| Markus, HS | 1 |
1 review available for n(g),n(g')-dimethyl-l-arginine and Cerebrovascular Disorders
| Article | Year |
|---|---|
Asymmetric Dimethylarginine (ADMA): a promising biomarker for cardiovascular disease?
Topics: Aging; Amidohydrolases; Arginine; Biomarkers; Cardiovascular Diseases; Cerebrovascular Disorders; Ch | 2013 |
10 other studies available for n(g),n(g')-dimethyl-l-arginine and Cerebrovascular Disorders
| Article | Year |
|---|---|
Asymmetric dimethylarginine exacerbates cognitive dysfunction associated with cerebrovascular pathology.
Topics: Amyloid beta-Protein Precursor; Animals; Arginine; Cerebrovascular Disorders; Cognitive Dysfunction; | 2020 |
The effects of Ramadan fasting on endothelial function in patients with cardiovascular diseases.
Topics: Adult; Arginine; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease; Endoth | 2014 |
Evaluation of asymmetric dimethylarginine and homocysteine in microangiopathy-related cerebral damage.
Topics: Arginine; Arteriosclerosis; Biomarkers; Blood Pressure; Brain Damage, Chronic; Cerebral Infarction; | 2009 |
ADMA and SDMA levels in healthy men exposed to tobacco smoke.
Topics: Adolescent; Adult; Arginine; Cerebrovascular Disorders; Coronary Vessels; Humans; Male; Middle Aged; | 2009 |
ADMA and the brain: an unfolding story.
Topics: Animals; Arginine; Brain Chemistry; Cattle; Cerebrovascular Circulation; Cerebrovascular Disorders; | 2009 |
Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial disease.
Topics: Aged; Arginine; Biomarkers; Cardiovascular Diseases; Cerebrovascular Disorders; Enzyme Inhibitors; E | 2011 |
Chronic renal failure alters endothelial function in cerebral circulation in mice.
Topics: Analysis of Variance; Animals; Apolipoproteins E; Arginine; Arterioles; Blotting, Western; Caveolin | 2011 |
Asymmetric dimethylarginine and cerebrovascular disorders in humans.
Topics: Arginine; Cerebrovascular Disorders; Humans; Nitric Oxide Synthase | 2006 |
Asymmetric dimethylarginine in cerebral small vessel disease.
Topics: Aged; Arginine; Cerebrovascular Circulation; Cerebrovascular Disorders; Female; Humans; Leukoaraiosi | 2007 |
Asymmetric dimethylarginine and hypertension in cerebral small vessel disease.
Topics: Arginine; Blood Pressure; Cerebrovascular Disorders; Enzyme Inhibitors; Humans; Hypertension; Leukoa | 2007 |